MDA effects on classical appetitive conditioning of the rabbit jaw movement response.
I Gormezano
Brain Research Bulletin 1994 DOI: 10.1016/0361-9230(94)90101-5 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled experimental animal study Peer reviewed |
|---|---|
| Population | Rabbits |
| Intervention | 3 |
| Dose | 0, 2, or 4 mg/kg |
| Duration | 10 daily sessions |
| Key findings | MDA (2 or 4 mg/kg) impaired acquisition of conditioned jaw movement responses to tone cues but enhanced responses to light cues across 10 daily sessions. A modest increase in nonassociative responses over days interacted with cue modality but could not account for the conditioning effects, which the authors attribute to MDA altering the intensity of the tone and light conditioned stimuli. |
Abstract
We determined MDA's effects on: (a) conditioning of the rabbit's jaw movement response (JMR) (Experiment 1); and (b) nonassociative JMRs and unconditioned JMRs (Experiment 2). Rabbits were administered 3,4-methylenedioxyamphetamine (MDA; 0, 2, or 4 mg/kg) into the marginal ear vein 20-30 min prior to each of 10 daily sessions. Experiment 1 involved 30 daily training trials of 15 tone- and 15 light-conditioned stimuli (CSs) paired with a 1-ml squirt of water, as the unconditioned stimulus (UCS), injected into the oral cavity. The study revealed that MDA impaired conditioned response (CR) acquisition to tone-CS trials while augmenting CRs to light-CSs. In Experiment 2, the animals received 15 tone- and 15 light CS-alone and 30 UCS-alone presentations daily. The study revealed that MDA produced a modest increase in nonassociative responses over days that interacted with CS modality. Accordingly, these nonassociative effects could not account for MDA's influences on CR acquisition. Moreover, MDA's decrementing and enhancing of CRs to tone- and light-CSs, respectively, appears to be attributable to the drug's enhancing or decrementing tone- and light-CS intensity.
Citations in the library
Cites 14
- Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity Journal of Neuroscience August 1, 1988
- 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. Journal of Pharmacology and Experimental Therapeutics September 1, 1987
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals Science September 6, 1985
- Methylenedioxyamphetamine (MDA)–Subjective Effects Journal of Psychedelic Drugs 1974
- Effects of MDA on classical conditioning of the rabbit nictitating membrane response. Pharmacology, Biochemistry, and Behavior May 1991
and 9 more in the library